Bayaca, Artemio D.
HRN: 21-28-23 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
04/27/2022
PIPERACILLIN + TAZOBACTAM 4.5G (VLS)
04/27/2022
05/04/2022
IVT
4.5g
Q6
HAP
Waiting Final Action
Indication: Empiric Type of Infection: Pneumonia Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes